All Type of News
Generic drugs in severe market competition.
The generic drugs have shown severe market competitions among many leading domestic companies who have tried to develop attractive generic drugs in an attempt to survive amid the recent protracted economic recession. ...
Drug exports on the rising trend.
The drug exports in Jan. and Feb. this year rose significantly compared to the same period last year, showing a bright perspective.
According to the Korea Trade data the drug export in Feb. this year amounted to ab...
Pharmacies to shun quasi-drugs
Pharmaceutical business sources say that many pharmacies has little interest in handling quasi-drugs due to their concentrated efforts to acquire more prescriptions, while quasi-drug makers are also shunning the pharm...
Arimidex to get 2nd indication as early breast cancer treatment.
The KFDA authorized Astra Zeneca's Arimidex (anastrozol) on April 4 for the early breast cancer treatment in addition to its original claims of the advancing breast cancer after menopause.
Arimidex, a 3rd generati...
Fluoroquinolone Factive acquires approval from US FDAAn antibiotic "Factive" developed by a local drug manufacturer has obtained an approval from the US FDA for the first time in Korea.
LG Life Sciences said recently that Facti...
|
Additional indications of Factive probable
LG Life Sciences' Factive has received an approval letter from the US FDA as treatment against community-acquired pneumonia and acute exacerbation of chronic bronchitis, and penicillin-resistant S.pneumoniae (PRSP), e...
KFDA underway of KGMP revisional works.
The KGMP seems to be upgraded at the level of the United States, EU and other advanced countries to ensure far strict administration of the drug quality and distribution systems before the end of this year, implementi...
Zuellig's business ethics stir dispute
Zuellig Pharma Korea has again faced a bombardment of criticism from domestic wholesalers acting as agents for the company in distributing products, over the following controversial issues including its recent compuls...
Handok-Aventis Pharma launches anti-rheumatic drug "Arava"Handok-Aventis Pharma has newly launched Arava (leflunomide), a new disease-modifying anti-rheumatic drug (DMARD) that reduces inflammation and slows disease progression of rheu...
|
Government to promote substitute drug dispensing
As part of its effort to ensure a firmer establishment of the separation of the separation of dispensing and prescribing (SDP function), the Ministry of Health and Welfare will considering allowing substitute drug dis...
